✨ Free AI Report
Abbott Laboratories (Pakistan) Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Abbott Laboratories (Pakistan) Limited
Company Research

Abbott Laboratories (Pakistan) Limited: Business Overview, Financials & Competitive Analysis

Abbott Laboratories (Pakistan) Limited scores 7/10 on the AskCyborg Cyborg Score (Solid). Established diversified pharmaceutical player with strong fundamentals and valuation appeal, executing growth strategy across emerging South Asian markets. Strong revenue growth of 22.90% YoY and exceptional earnings growth of 1899.50% demonstrate operational momentum. Market cap of 101.53 billion PKR reflects solid market position, though recent performance underperformed both.

What is Abbott Laboratories (Pakistan) Limited's industry? Abbott Laboratories (Pakistan) Limited (abbottpakistan.com) operates in Pharmaceuticals & Healthcare (Branded Generics, Nutritional Products, Diagnostics). AskCyborg classifies Abbott Laboratories (Pakistan) Limited under Pharmaceuticals & Healthcare (Branded Generics, Nutritional Products, Diagnostics) in its company registry.

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948, principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional...

7/ 10Solid

Cyborg Score thesis

Established diversified pharmaceutical player with strong fundamentals and valuation appeal, executing growth strategy across...

Read the full analyst-debate transcript →
Industry Pharmaceuticals & Healthcare (Branded Generics, Nutritional Products, Diagnostics)
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Abbott Laboratories (Pakistan) Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Abbott Laboratories (Pakistan) Limited

AskCyborg analysts argue the bull and bear cases for Abbott Laboratories (Pakistan) Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Abbott Laboratories (Pakistan) Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Abbott Laboratories (Pakistan) Limited Overview

Pro stress-test →

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948, principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products. The company operates across Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.

Strategic Profile

Pro stress-test →

In 2024, revenue reached 68.18 billion PKR (up 22.90% YoY) with earnings of 5.23 billion PKR. The company operates through four segments: Pharmaceutical, Nutritional, Diagnostics, and Others, leveraging strong brand recognition with products like Similac, PediaSure, and Ensure in the nutritional category. The company trades at a P/E ratio of 20x, below the pharmaceuticals industry average of 22.4x.

Competitive Landscape

Pro stress-test →

Abbott Pakistan operates in a competitive South Asian pharmaceutical market dominated by established players. The company competes across multiple segments (pharma, nutrition, diagnostics) with international brand advantages and local market presence. The broader Pakistani pharmaceutical sector has shown strong growth momentum, though Abbott underperformed industry returns over the past year.

Industry Context

Abbott Laboratories (Pakistan) Limited operates in Pharmaceuticals & Healthcare (Branded Generics, Nutritional Products, Diagnostics).

Key facts

Founded: 1948 · Headquarters: Karachi, Pakistan · Employees: 1,410 · Revenue: 68.18B PKR (2024) · Market cap: 101.53B PKR

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Abbott Laboratories (Pakistan) Limited.

  • Revenue growth of 22.90% YoY to 68.18 billion PKR demonstrates solid market traction in pharmaceutical, nutritional, and diagnostic segments
  • Strong portfolio of global nutritional brands including Similac, PediaSure, Pedialyte, Ensure, and Glucerna positions the company in high-margin consumer health segment
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • 2024Revenue reached 68.18 billion PKR, up 22.90% YoY with exceptional earnings growth
  • 2025Dividend yield of 0.96% with consistent payout policy maintained
  • +1 moreTrack every material event for Abbott Laboratories (Pakistan) Limited as it happens. Explore monitoring →
Get alerted when Abbott Laboratories (Pakistan) Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Pharmaceutical ProductsMajor competitor in branded generic pharmaceuticals→Nutritional ProductsLeading competitor in nutritional and consumer health→Diagnostic SolutionsCompetitor in diagnostic equipment and molecular devices→

Compare Abbott Laboratories (Pakistan) Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Abbott Laboratories (Pakistan) Limited operates in Pharmaceuticals & Healthcare (Branded Generics, Nutritional Products, Diagnostics). See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals & Healthcare (Branded Generics, Nutritional Products, Diagnostics) research →
NEW · MCP server

Ask your AI assistant about Abbott Laboratories (Pakistan) Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Abbott Laboratories (Pakistan) Limited and its top competitor on Cyborg Score”
“What did Abbott Laboratories (Pakistan) Limited do this quarter?”
“Is Abbott Laboratories (Pakistan) Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Abbott Laboratories (Pakistan) Limited do?+
Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948, principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional...
What is Abbott Laboratories (Pakistan) Limited's Cyborg Score?+
Abbott Laboratories (Pakistan) Limited has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Abbott Laboratories (Pakistan) Limited's main competitors?+
Named competitors include Pharmaceutical Products, Nutritional Products, Diagnostic Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Abbott Laboratories (Pakistan) Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Abbott Laboratories (Pakistan) Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Abbott Laboratories (Pakistan) Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.